Neurocrine Biosciences Inc. (NBIX)
Market Closed
15 Oct, 08:00 PM
$
136. 95
+1.04
+0.7652%
$
14.32B Market Cap
63.27 P/E Ratio
- Div Yield
1.38M Volume
2.29 Eps
$ 135.91
Previous Close 
Want to track NBIX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Neurocrine Biosciences Inc. (NBIX) Statistics
Valuation metrics
Market Cap 14.32B
Enterprise value 14.39B
Trailing P/E (ttm) 20.2
Forward P/E 9.91
PEG ratio 0.2
Price/Sales (ttm) 4.25
Price/Book (mrq) 3.89
Enterprise Value/Revenue 4.27
Enterprise Value/EBITDA 15.68
Overview
Shares outstanding 100.1M
Float 99.08M
Shares short 5.64M
% Held by insiders 0.01%
% Held by institutions 1.01%
Average volume (10 days) 1.02M
Average volume (90 days) 1.49M
Price summary
52-Week low 122.14
52-Week high 186.12
Beta 0.35
50-Day moving average 147.91
200-Day moving average 148.05
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin 0.21%
Operating margin 0.23%
Operational effectiveness
Return on assets 0.13%
Return on equity 0.21%
Income Statement
Revenue (ttm) 2.86B
Revenue per share (ttm) 33.4
Quarterly revenue growth (yoy) 0.28%
Gross profit (ttm) 1.79B
EBITDA 688M
Net income to common (ttm) 478.6M
Diluted EPS (ttm) 6.99
Quarterly earnings growth (yoy) 0.49%
Balance Sheet
Total cash (mrq) 1.48B
Total cash per share (mrq) 3.86
Total debt (mrq) 471.3M
Total Debt/Equity (mrq) 0.11
Current ratio (mrq) 1.87%
Book value per share (mrq) 36.57
Cash Flow
Cash flow statement 782.7M
Levered free cash flow (LFCF) 397.81M
2026 © Marketlog. All Rights Reserved.
